Sign in Pull a receipt

AZN

ASTRAZENECA PLC

Pharmaceuticals · Pharmaceuticals

$246.17 sample

-0.76 (-0.31%) 1D

Market cap

$514.4B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-20

Alerts

8

Price$246.17 -14.64% 3M daily closessample

293.29242.85

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: 10% owner
Oct 20SECForm 144 filed
Oct 15SECForm 144 filed
Oct 06INSInsider sell: 10% owner
Sep 28INSInsider buy: General Counsel
Sep 22INSInsider sell: General Counsel
Sep 11INSInsider sell: 10% owner
Sep 08SEC10-Q filed

Sign up to see the real AZN record →

Company facts

SEC EDGAR registration

Name: ASTRAZENECA PLC
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +1sample, -100 to +100
Reporting currency: USD

Who is positioning in AZN

sample

Insiders: 31 insider transactions over 90 days, net selling, $899.8M
Congress: 3 members traded over 90 days
Institutions · 13F: 8 funds hold $10.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.9B +24.7% y/y

Q4 2024Q3 2026

Inventory$13.2B +6.2% y/y

Q4 2024Q3 2026

Accounts receivable$9.6B +13.6% y/y

Q4 2024Q3 2026

Total debt$26.9B +14.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $179.5B -13.3% 3M
Sample peer B: $68.7B -6.5% 3M
Sample peer C: $232.9B +13.6% 3M
Sample peer D: $450.3B +5.9% 3M
Sample peer E: $128.9B +4.8% 3M